Intervention Protocol
Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in patients with previous adenomas and/or genetic disposition
Editorial Group: Cochrane Colorectal Cancer Group
Published Online: 31 JAN 2013
Assessed as up-to-date: 19 NOV 2012
DOI: 10.1002/14651858.CD010291
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Database Title
Additional Information
How to Cite
Latchford AR, Maeda Y, Clark SK. Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in patients with previous adenomas and/or genetic disposition (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD010291. DOI: 10.1002/14651858.CD010291.
Publication History
- Publication Status: New
- Published Online: 31 JAN 2013
- Abstract
- Article
- References
- Cited By
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows:
To determine if administration of nonsteroidal anti-inflammatory drugs (NSAID) and/or aspirin is effective as chemoprevention for colorectal adenomas and carcinomas in patients with previous colorectal adenomas and/or those who have genetic predispositions, compared to currently available other agents or no intervention and to assess adverse effects associated with the intervention.
The following hypotheses will be tested:
1. NSAID and/or aspirin is better than no intervention
2. NSAID and/or aspirin is better than a placebo/sham intervention;
3. Aspirin with combination of resistant starch is better than no intervention;
4. One type of NSAID is better than another type;
5. Increased dose of NSAID and/or aspirin is better than another dose.
